Kuzuya T, Ishigami M, Ito T, Ishizu Y, et al. Sorafenib vs. Lenvatinib as First-line Therapy for Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis. Anticancer Res 2020;40:2283-2290.
PMID: 32234927